Connection
Edward Yeh to Clinical Trials as Topic
This is a "connection" page, showing publications Edward Yeh has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.382 |
|
|
|
-
Vejpongsa P, Yeh ET. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J Am Coll Cardiol. 2014 Sep 02; 64(9):938-45.
Score: 0.100
-
Leja MJ, Yeh ET. Cardiovascular risk associated with androgen deprivation therapy. Oncology (Williston Park). 2010 Aug; 24(9):799, 803, 806.
Score: 0.075
-
Calabr? P, Golia E, Yeh ET. CRP and the risk of atherosclerotic events. Semin Immunopathol. 2009 Jun; 31(1):79-94.
Score: 0.069
-
Khakoo AY, Yeh ET. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nat Clin Pract Oncol. 2008 Nov; 5(11):655-67.
Score: 0.066
-
Calabro P, Yeh ET. Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases. Curr Atheroscler Rep. 2004 Jan; 6(1):36-41.
Score: 0.048
-
Simari RD, Pepine CJ, Traverse JH, Henry TD, Bolli R, Spoon DB, Yeh E, Hare JM, Schulman IH, Anderson RD, Lambert C, Sayre SL, Taylor DA, Ebert RF, Moy? LA. Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network. Circ Res. 2014 May 09; 114(10):1564-8.
Score: 0.024